Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,200,289
  • Shares Outstanding, K 68,514
  • Annual Sales, $ 117,910 K
  • Annual Income, $ -411,470 K
  • 60-Month Beta 2.42
  • Price/Sales 28.86
  • Price/Cash Flow N/A
  • Price/Book 4.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -1.71
  • Number of Estimates 4
  • High Estimate -1.54
  • Low Estimate -1.99
  • Prior Year -1.59
  • Growth Rate Est. (year over year) -7.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.72 +5.38%
on 02/25/20
54.08 -10.91%
on 02/20/20
-5.02 (-9.15%)
since 01/24/20
3-Month
36.58 +31.73%
on 11/27/19
54.68 -11.89%
on 01/22/20
+10.71 (+29.17%)
since 11/26/19
52-Week
28.36 +69.89%
on 10/31/19
68.94 -30.11%
on 03/04/19
-15.17 (-23.74%)
since 02/26/19

Most Recent Stories

More News
Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Cowen...

AGIO : 48.09 (+2.95%)
Agios' (AGIO) Q4 Loss Narrower Than Expected, Revenues Beat

Agios (AGIO) rides high on earnings and revenue beat in the fourth quarter of 2019.

BMY : 62.10 (-0.06%)
AGIO : 48.09 (+2.95%)
VCEL : 14.92 (-10.61%)
KALA : 6.02 (-1.63%)
Novavax Inc is Among the Companies in the Biotechnology Industry with the Best Relative Performance (NVAX , AGIO , IRWD , ESPR , ACAD )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AGIO : 48.09 (+2.95%)
IRWD : 11.06 (-0.18%)
NVAX : 9.32 (+17.23%)
Agios Pharmaceuticals: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $102.4 million in its fourth quarter.

AGIO : 48.09 (+2.95%)
Agios Reports Fourth Quarter and Full Year 2019 Financial Results

- Fourth Quarter TIBSOVO Net Revenue of $19.6M and $59.9M for Full Year 2019; Full Year 2020 U.S. TIBSOVO Net Revenue Expected to be Between $105-115 Million -

AGIO : 48.09 (+2.95%)
Agios to Present at the Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Leerink...

AGIO : 48.09 (+2.95%)
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: Should You Buy?

Agios Pharmaceuticals (AGIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AGIO : 48.09 (+2.95%)
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference call and live...

AGIO : 48.09 (+2.95%)
Agios Pharmaceut Up 55.5% Since SmarTrend Uptrend Call (AGIO)

SmarTrend identified an Uptrend for Agios Pharmaceut (NASDAQ:AGIO) on November 13th, 2019 at $34.38. In approximately 2 months, Agios Pharmaceut has returned 55.53% as of today's recent price of $53.47....

AGIO : 48.09 (+2.95%)
Uptrend Call Working As Agios Pharmaceut Stock Rises 47.2% (AGIO)

SmarTrend identified an Uptrend for Agios Pharmaceut (NASDAQ:AGIO) on November 13th, 2019 at $34.38. In approximately 2 months, Agios Pharmaceut has returned 47.21% as of today's recent price of $50.61....

AGIO : 48.09 (+2.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade AGIO with:

Business Summary

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts....

See More

Key Turning Points

2nd Resistance Point 51.98
1st Resistance Point 49.35
Last Price 48.09
1st Support Level 44.90
2nd Support Level 43.08

See More

52-Week High 68.94
Fibonacci 61.8% 53.44
Fibonacci 50% 48.65
Last Price 48.09
Fibonacci 38.2% 43.86
52-Week Low 28.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar